IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
Health. Pharmaceuticals; Con sumer Healthcare;
Ophthalmics; Optics; Branded Generics.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 51-100 (2005)
Con tacts (Pharm): Chair man: Maria Cristina
Alvarez; Com mer cial Op er a tions: Javier Gabela;
Mar ket Re search: Mil ton Mo rales; Re search & De -
vel op ment: Edwin Cabrera; Gen eral Con tact:
Milton Morales
Par ent of: Sandoz, Ec ua dor (di vi sion).
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 20-22 mil lion
Prod ucts (% of Sales by Lead ing 5): 40-45%
Ther a peu tic Classes (% of Sales by Lead ing
5): 75-80%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
CATAFLAM (antirheumatic non-steroidal)
DIOVAN HCT (an gio ten sin-II an tag o nist com bi na -
tion)
VOLTAREN (antirheumatic non-steroidal)
DIOVAN (an gio ten sin-II an tag o nist plain)
PREXIGE (antirheumatic non-steroidal)
Ther a peu tic Range:
anti rheu ma tics sys temic 26%
renin-an gio ten sin sys tem agents 21%
ophthalmologicals 15%
antiepileptics 10%
ant ac ids/antiflatulents/antiulcerants 5%
Lead ing Dose Forms:
coated tab lets 49%
tab lets 21%
liq uids 14%
cap sules 5%
am poules 3%
NOVARTIS OPHTHALMICS
Full Name: Novartis Ec ua dor S.A.
Postal Ad dress: Casilla 17-11-06201, Quito
Street Ad dress: Av. Republica del Sal va dor
N34-107 y Suiza, Edificio Brescia 3, 4, 5 to Piso,
Quito
Tel: +593 2 246-4039
Fax: +593 2 246-1394
Home Page: www.novartis.com
De scrip tion: Packager/as sem bler, ex porter, dis -
trib u tor. Prod uct ranges in clude: phar ma ceu ti cal
prod ucts (branded, pre scrip tion, non-pre scrip -
tion), oph thal mic prod ucts. Es tab lished 1997. 130
phar ma ceu ti cal employees in 2006.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 51-100 (2006)
Con tacts (Pharm): Chair man: Maria Cristina
Alvarez; Com mer cial Op er a tions: Javier Gabela;
Mar ket Re search: Paul Solorzano; Re search & De -
vel op ment: Edwin Cabrera; Gen eral Con tact: Mil -
ton Morales
SANDOZ
Postal Ad dress: Casilla 17-11-06201, Quito
Street Ad dress: Av. Republica del Sal va dor
N34-107 y Suiza, Edificio Brescia, 3rd Piso Of.
301, Quito
Tel: +593 2 246-4422
Fax: +593 2 225-1952
De scrip tion: De vel oper, im porter, dis trib u tor,
pro moter, sales/detailer. Prod uct ranges in clude:
phar ma ceu ti cal prod ucts (branded, pre scrip tion),
hos pi tal pharmaceuticals. Es tab lished 1989. 27
phar ma ceu ti cal employees in 2006.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 20 (2006)
Con tacts (Pharm): Chair man: Harry Yepez
Meisner; Com mer cial Op er a tions: Harry Yepez
Meisner; Mar ket Re search: Marcela Carrillo; Gen -
eral Con tact: Harry Yepez Meisner
Sub sid iary of: Novartis, Ec ua dor (di vi sion)
Phar ma ceu ti cal Sales: US$ 7-8 mil lion
Prod ucts (% of Sales by Lead ing 5): 60-65%
Ther a peu tic Classes (% of Sales by Lead ing
5): 90-95%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
CURAM (pen i cil lin broad spec trum)
BINOZYT (macrolide/sim i lar type)
BENZETACIL (pen i cil lin me dium/nar row spec -
trum)
BIODROXIL (cephalosporin)
SERVAMOX (pen i cil lin broad spec trum)
Ther a peu tic Range:
antibacterials sys temic 78%
antifungals sys temic 4%
musculoskeletal drugs other 4%
renin-an gio ten sin sys tem agents 4%
lipid-reg u lat ing/antiatheroma prep a ra tions 2%
Lead ing Dose Forms:
coated tab lets 31%
liq uids 26%
tab lets 15%
cap sules 13%
vi als 10%
© 2009 IMS Health In cor po rated or its af fil i ates Page 164